2,2-Dimethyl-5-(((4-(p-tolyl)thiazol-2-yl)amino)methylene)-1,3-dioxane-4,6-dione

Catalog No. :
ACURXJ132
CAS No. :
928821-87-8
Molecular Formula :
C17H16N2O4S
Molecular Weight :
344.39

IUPAC Name:2,2-dimethyl-5-(((4-(p-tolyl)thiazol-2-yl)amino)methylene)-1,3-dioxane-4,6-dione

2,2-Dimethyl-5-(((4-(p-tolyl)thiazol-2-yl)amino)methylene)-1,3-dioxane-4,6-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$120.00Login to see priceInquiryInquiry
10mg98%$147.00Login to see priceInquiryInquiry
250mg98%$637.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2-Dimethyl-5-(((4-(p-tolyl)thiazol-2-yl)amino)methylene)-1,3-dioxane-4,6-dione
IUPAC Name2,2-dimethyl-5-(((4-(p-tolyl)thiazol-2-yl)amino)methylene)-1,3-dioxane-4,6-dione
Molecular FormulaC17H16N2O4S
Molecular Weight344.39
SMILESO=C(C1=CNC2=NC(C3=CC=C(C)C=C3)=CS2)OC(C)(C)OC1=O
InChI KeyGOZNRJONTNNVAT-UHFFFAOYSA-N
Synonym2,2-DIMETHYL-5-(((4-(4-METHYLPHENYL)(2,5-THIAZOLYL))AMINO)METHYLENE)-1,3-DIOXANE-4,6-DIONE;2,2-dimethyl-5-({[4-(4-methylphenyl)-1,3-thiazol-2-yl]amino}methylidene)-1,3-dioxane-4,6-dione;1,3-Dioxane-4,6-dione, 2,2-dimethyl-5-[[[4-(4-methylphenyl)-2-thiazolyl]amino]methylene]-
CAS No.928821-87-8

Synthetic Route by SureRoute

1. ACURXJ132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGFZK852 route compound structure diagram
    ACGFZK8522103-91-5 In Stock
  4. Then
  5. ACURXJ132 route product structure diagram
    ACURXJ132928821-87-8
Inquiry

2. ACURXJ132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACURXJ132 route product structure diagram
    ACURXJ132928821-87-8
Inquiry

Comments (0)